Prime Minister Andy Burnham has announced a £48 million commercial partnership aimed at accelerating dementia research, responding to the pressing need for advancements in treatment. Burnham emphasized the pivotal role of this initiative following the recent death of his father, Roy, from Alzheimer’s, stating he wants Britain “to be the country that makes the breakthrough,” reports BritPanorama.
The commitment includes a government investment of £33 million, complemented by funding from Bristol Myers Squibb, GSK, and Gates Ventures, which aims to recruit more participants for clinical studies.
During a statement made ahead of Friday’s Innovation Nation Summit in Manchester, Burnham remarked, “Dementia is a devastatingly cruel disease, not only for those who live with it, but for the families who care for them.” He expressed that society has long regarded dementia merely as a condition to be managed in later life, rather than as a disease that can be conquered.
Furthermore, Burnham expressed hope for collaborative efforts to achieve breakthroughs in dementia research. “I want Britain to be the country that makes the breakthrough and delivers the cure for dementia the world has been waiting for,” he said. This initiative is tied to broader plans for a National Care Service, aimed at ensuring those with dementia receive necessary care, while also providing families with reassurance regarding the support of their loved ones.
The investment will bolster The Barbara Alliance, established in memory of EastEnders star Dame Barbara Windsor, which is dedicated to expediting the development of new dementia treatments. A new platform will integrate health records, scientific data, and clinical trial infrastructure to streamline candidate selection for forthcoming studies.
Dementia will be prioritized under the new Health Data Research Service, which is backed by up to £600 million from the Government and the Wellcome Trust. This service will combine NHS and research data to assist scientists in identifying suitable patients for trials.
Health and Social Care Secretary Yvette Cooper commented on the initiative, highlighting the often devastating impact of dementia on families across the country and the historical lack of resources to combat the disease. She expressed hope that this investment will facilitate faster diagnoses, enhance research capabilities, and increase participation in transformative clinical trials.
In response to the government’s announcement, Dame Barbara’s husband, Scott Mitchell, reflected on their advocacy for increased funding for dementia support. He remarked on the significance of today’s announcement, stating that it offers a second legacy for Barbara, beyond her fame, and is a hopeful step forward in dementia care and research.
This robust commitment underlines the UK’s renewed focus on combating dementia, an area long deemed in need of attention and investment as families continue to grapple with its challenges.
